Cardiac Rehabilitation for Cardiovascular Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates how exercise-based cardiac rehabilitation affects brain blood flow and cognitive function in people with cardiovascular disease. Participants will be divided into groups to receive different exercise programs, such as high-intensity interval training (HIIT) or moderate-intensity continuous training (MICT), and their results will be compared to a control group. The goal is to determine if exercise can improve or maintain cognitive abilities by positively influencing brain blood flow. Individuals who have experienced a cardiac event and are eligible for rehab might be a good fit for this trial. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance rehabilitation strategies for cardiovascular patients.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more information.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) are safe and well-tolerated for people in cardiac rehab. HIIT carries a low risk of serious heart problems in patients with coronary artery disease or heart failure. Studies indicate that HIIT can boost fitness and health without increasing health risks.
Similarly, MICT improves fitness and exercise ability without causing additional heart issues. This training also helps lower death rates and enhances quality of life for those with heart disease. Overall, both exercise programs are considered safe for people in cardiac rehab.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores different styles of cardiac rehabilitation, which could reshape how we approach recovery for cardiovascular disease. Traditional rehab often focuses on moderate exercise, but this study is testing high-intensity interval training (HIIT), which alternates short bursts of intense activity with rest. This method may improve heart health more efficiently and in less time. Additionally, the trial includes an observational group to better understand outcomes in real-world settings. By comparing these approaches, the trial aims to find the most effective way to boost heart recovery and overall fitness.
What evidence suggests that this trial's treatments could be effective for cardiovascular disease?
This trial will compare different cardiac rehabilitation approaches for cardiovascular disease. Research has shown that exercise programs for heart health, such as high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), can be very beneficial. Participants in this trial may be randomized to receive either HIIT or MICT. Studies have found that HIIT can boost heart fitness and lower the risk of heart disease, sometimes even more effectively than MICT. HIIT is also linked to fewer serious heart problems in individuals with coronary artery disease. Meanwhile, MICT reduces the risk of heart issues and death by focusing on longer, moderate workouts. Both HIIT and MICT are safe and improve overall heart fitness.12346
Who Is on the Research Team?
Bruce D Johnson, PhD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for people aged 40 and older who are eligible for cardiac rehab after a heart-related hospital stay. It's open to those with coronary artery disease but not to individuals previously diagnosed with cardiovascular diseases or risk factors like high blood pressure, high cholesterol, diabetes, obesity (BMI >30), or smoking.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either high intensity interval training (HIIT) or moderate intensity continuous training (MICT) as part of cardiac rehabilitation
Follow-up
Participants are monitored for changes in cerebral blood flow regulation and cognitive function
Observational Control
Participants who decline cardiac rehabilitation are monitored as a control group
What Are the Treatments Tested in This Trial?
Interventions
- Cardiac rehabilitation - control
- Cardiac rehabilitation - high intensity interval training (HIIT)
- Cardiac rehabilitation - moderate intensity continuous training (MICT)
- Cardiac rehabilitation - observational
Cardiac rehabilitation - control is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Cardiovascular disease
- Heart failure
- Coronary artery disease
- Cardiovascular disease
- Heart failure
- Coronary artery disease
- Cardiovascular disease
- Heart failure
- Coronary artery disease
- Cardiovascular disease
- Heart failure
- Coronary artery disease
- Cardiovascular disease
- Heart failure
- Coronary artery disease
- Cardiovascular disease
- Heart failure
- Coronary artery disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor